The residential MS MasterClasses are specifically designed to advance your skills in MS.

Based on our 16 year-strong model of interactive learning and a core application of knowledge into practice, our residential MS MasterClasses have been developed specifically to meet you in your educational needs.

Designed to advance your skills, expertise and understanding in a meaningful way, our courses aim to deliver a learning experience that extends beyond the ‘classroom’ and will directly impact your professional practice.

With an array of inspirational speakers drawing on their practical experience, course attendees can develop in everything from clinical expertise to patient focus, service delivery to cutting-edge treatment options.

By giving you the knowledge, tools, and a network of like-minded peers, the MS MasterClasses aim to equip you to increase in confidence, ability and passion, so that you can be part of the drive to deliver optimal care and support for people living with MS.

MSologists MasterClass

Our most in-depth exploration into the complexities of MS management and treatment, this course is for specialists who want to really hone their expertise and maximise their impact on patient outcomes. If you are a currently prescribing neurologist, a final-year registrar, an experienced MS specialist nurse or a pharmacist working with MS therapies, this course is the next level in learning meets application.

General MS MasterClass

This course is our original residential course comprising two modules sandwiching an inter-module project aiming to practically improve MS services and support in their area. If you are a general or non-prescribing neurologist, a registrar or a pharmacist looking to specialise in MS then this is the right course for you.

Foundation MasterClass

An essential course in the fundamentals of MS clinically, as well as in terms of lived experience with MS and optimal service support, this is the ideal introduction to MS as a specialism. If you are a clinical nurse specialist (CNS), a GP with a newly developing special interest in MS (GPwSI) or an Associate Specialist with a special interest in neurology then this course could be perfect for you.

Intermediate MasterClass

Our more in-depth course, this MasterClass covers residential training from a varied array of experts specialising in anything from atypical presentations to cutting edge treatments, a new take on palliative care to groundbreaking service redesign and delivery. Practical learning alongside mentorship and an ongoing research project of your choice to conduct locally, this is the course for those looking to really deepen their specialism and optimise their practice. If you are a general or non-prescribing neurologist, a registrar looking to develop a specialism, a pharmacist or more senior clinical nurse specialist (CNS), this course is a must.

Neuropharmacy MasterClass

This Neuropharmacy MasterClass is designed for specialist pharmacists who are already working in neurology and want to enhance their skills in MS, headache disorders, Parkinson’s and epilepsy. The course is ideally for pharmacists who are band 7 or above, and assumes a level of knowledge about the pathology of the conditions and their treatment options.

Palliative Care MasterClass (includes Parkinson's, dementia, MS & MND)

For health professionals involved in palliative care for neurological conditions largely focused on Parkinson’s and dementia – including allied health professionals, doctors (grade SpR and above), specialist nurses, community teams and GPs


What our delegates say:

“Thanks for all your hard work – it will undoubtedly make a difference to the lives of patients”

“Gosh! I certainly learnt a lot more about MS than I ever thought possible”

“Excellent course, wish this would have been available when I started our MS service 13 years ago.”

Best course I have ever been on, thank you”

“Really great and thought provoking

“Another very useful, informative and excellently delivered session”


MS Service Provision in the UK; the Way Forward

Variance in MS Services, for example, access to and the prescribing of disease-modifying therapies, have been well documented across England by surveys performed by the MS Society, MS Trust and the RCP. This has been backed up by data presented at the ABN in Birmingham from the NHSE Bluteq database. We and others feel this is a problem for people living with MS and is a barrier to improving outcomes for pwMS being managed by the NHS in England. To address this problem we held an initial meeting of representatives from MS DMT prescribing centres across England. The aim of the meeting was to generate ideas and proposals to address and solve this problem. We envisage holding subsequent follow-on meetings to implement and test potential proposals developed as a result of this meeting.